SPES is a specialty pharmaceutical company focusing on patient medical needs through innovative science and technologies. The company is developing twelve 505(b)(2) products based on three innovative platforms. The candidate products are targeting therapeutic areas including oncology, antiemetic, CNS, and pain management to provide patients with